Tip Of The Iceberg? Turkey’s Largest Pharma Company At Center Of Controversy Over Industry Standards
This article was originally published in PharmAsia News
Abdi Ibrahim, the top pharmaceutical company in Turkey, finds itself at the center of controversy after questioning the government’s pricing policies and then getting into a nasty dispute with sales reps over allegedly fake invoices. And the story has now spread, with local media questioning pharmaceutical industry practices in Turkey.